DSIP

Buy DSIP Online

Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide primarily researched for sleep regulation, sleep quality, stress response, and neurophysiological effects.

Product Information

DSIP has been investigated in both animal models and human sleep studies. Early clinical research examined its effects in people experiencing chronic insomnia and disturbances in sleep architecture.

How It Works

DSIP appears to interact with mechanisms involved in sleep regulation rather than acting as a conventional sedative. Human research has investigated changes in sleep latency, sleep efficiency and sleep architecture following administration.

POTENTIAL BENEFITS

1. Sleep Research

DSIP has been investigated for its ability to influence sleep duration, sleep efficiency and sleep onset. Several older human studies reported improvements in selected sleep parameters.

2. Sleep-Quality Research

Research has examined whether DSIP can improve the overall structure and continuity of sleep rather than simply producing conventional sedation.

3. Stress & Recovery Research

DSIP has attracted research interest because sleep regulation is closely connected with physiological stress and recovery processes.

4. Daytime Performance

Some older clinical research reported improvements in daytime alertness and performance following DSIP treatment in people with chronic insomnia.

Dosage

Older human studies used 25 nmol/kg intravenously in experimental insomnia protocols. Online peptide communities commonly discuss much smaller amounts, often around 100–200 mcg before bedtime, but these community protocols are not medically established.

Side Effects

Older clinical studies generally reported good short-term tolerability. Headache, dizziness, daytime tiredness or sleepiness may occur, particularly depending on dose and individual response.

References

• Schneider-Helmert D, et al. Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 6895513.
• Monti JM, et al. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. Int J Clin Pharmacol Res. 1987. PMID: 3583493.
• Schneider-Helmert D. Effects of delta sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia. Eur Neurol. 1987. PMID: 3622582.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to access instructions on how to make a payment.

How to Pay